Gilt mutual funds: ICICI Prudential tops 5-year returns at over 6%; all 23 schemes remain in the green
Gilt mutual funds invest predominantly in government securities. Under the category definition, these open-ended debt schemes must invest at least 80% of their total assets in government securities, across maturities.
Since these funds hold sovereign debt, their returns are influenced largely by changes in government bond yields and interest rates.
Billionaire Bill Ackman Dumps Alphabet and Loads Up On a Mega-Cap Stock Down 15% From Its Peak
Key Points
-
Meta Platforms’ stock has been on a tear in September.
-
Alphabet’s share price performance was rather flat over Q2.
Bill Ackman runs Pershing Square Capital Management, and the investment firm made some interesting investment moves this year.
Read MoreFed's Kashkari says inflation is still too high across US economy, in Fox News interview
By Doina Chiacu
Sept 20 (Reuters) – Minneapolis Federal Reserve President Neel Kashkari said on Sunday that inflation is too high across all sectors of the US economy, not just in rising oil prices.
“So even if we strip out energy, which is really volatile, and strip out food — they matter a lot — but in terms of where the economy is going,
Read MoreFed's Kashkari reportedly says inflation is still too high across the U.S. economy
Neel Kashkari
Kate Rooney | CNBC
Minneapolis Federal Reserve President Neel Kashkari said Sunday that inflation is too high across all sectors of the US economy, not just from rising oil prices.
“So even if we strip out energy,
3 Big Tech Stocks With the Most Upside Right Now
Wall Street has targets for Google, NVIDIA, and Salesforce, but one analyst thinks those numbers still leave serious money on the table heading into 2027. Here is the math behind three bold calls that could reshape how you size your…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
» Read more about: 3 Big Tech Stocks With the Most Upside Right Now »
Read MoreThe Burst
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read MoreThe Ivy
Will This ETF 2x Before Year End?
In recent months, some of the most sophisticated investors on Wall Street have made a bold move by pouring hundreds of millions into BlackRock’s iShares Bitcoin Trust (IBIT).
This isn’t just a passing trade but a conviction bet that Bitcoin’s best days may still be ahead and while still trading under $100,000 per coin,
» Read more about: Will This ETF 2x Before Year End? »
Read MoreThe Spotlight
Why This Beverage Giant Can’t Be Toppled
A famous book on business was titled Barbarians at the Gate, documenting the leveraged buyout of RJR Nabisco. If nothing else, it highlights how just the sniff of an opportunity to make money can drive money seekers to make wild decisions.
Some giant businesses have been on the receiving end of similar threats to their solvency as invaders attempt to take their share.
» Read more about: Why This Beverage Giant Can’t Be Toppled »